Doximity, Inc. (DOCS) Stock Forecast

NYSE: DOCSAnalyst ratings, price target and estimates.

DOCS analyst forecast

as of October 18, 2026
Analyst consensus
Hold
3.38 / 5 from 21 analysts
Price target
$30.44
average of analyst targets
Upside to target
−1.7%
from the latest close
Next earnings
November 5, 2026
EPS estimate $0.19
52-week range
$18.01 – $68.50

DOCS analyst ratings

21 analysts
Strong buy
314%
Buy
524%
Hold
1152%
Sell
15%
Strong sell
15%

Number of analysts at each rating.

DOCS price target

Price $30.97Target $30.44
52-week low $18.0152-week high $68.50

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

DOCS earnings per share estimates

Doximity, Inc. EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)$0.35$0.32$0.40$0.45−22.1%18
Next quarter (Dec '26)$0.42$0.37$0.49$0.46−9.2%18
Current fiscal year (FY2027)$1.35$1.23$1.49$1.52−10.9%18
Next fiscal year (FY2028)$1.56$1.32$1.78$1.35+15.0%17

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

DOCS revenue estimates

Doximity, Inc. revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$170.8M$170.2M$176.5M+1.4%18
Next quarter (Dec '26)$193.9M$171.0M$201.4M+4.8%19
Current fiscal year (FY2027)$677.6M$672.3M$691.4M+5.1%20
Next fiscal year (FY2028)$723.0M$698.8M$743.4M+6.7%19

DOCS EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

DOCS revenue: reported and forecast

Reported revenueEstimate (average; low–high)

DOCS EPS estimate revisions

Doximity, Inc. EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)$0.37$0.35$0.35$0.35$0.35−6.1%2 up · 13 down
Next quarter (Dec '26)$0.44$0.42$0.42$0.42$0.42−5.8%3 up · 13 down
Current fiscal year (FY2027)$1.43$1.36$1.35$1.35$1.35−5.6%1 up · 0 down
Next fiscal year (FY2028)$1.59$1.59$1.55$1.55$1.56−2.3%2 up · 11 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

DOCS earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; DOCS beat in 10 of 12.

What analysts expect from DOCS

21 analysts cover Doximity; their consensus rating is hold (3.38 on a 1–5 scale, where 5 is a strong buy). The average price target is $30.44, 1.7% below the latest close of $30.97. Analysts expect earnings of $1.35 per share for FY2027, −10.9% from a year earlier. For FY2028 the average estimate is $1.56 per share on revenue of $723.0 million. Doximity beat the EPS estimate in 10 of the last 12 quarters.

Related: DOCS income statement, DOCS key metrics, DOCS chart. See the DOCS stock overview for the latest quote and news.

DOCS forecast FAQ

What is Doximity's price target?

The average analyst price target for Doximity is $30.44, 1.7% below the latest close of $30.97.

Is Doximity a buy, hold or sell?

Of 21 analysts covering Doximity, 3 rate it a strong buy, 5 a buy, 11 a hold, 1 a sell and 1 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.

What is Doximity's EPS forecast?

Analysts forecast $1.35 per share for FY2027 (range $1.23 to $1.49); for FY2028 the estimate is $1.56.

What is Doximity's revenue forecast?

The average revenue estimate for FY2027 is $677.6 million, growth of 5.1%; for FY2028 it is $723.0 million.

When does Doximity report earnings?

Doximity is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.19.

Does Doximity usually beat earnings estimates?

Doximity reported EPS at or above the analyst estimate in 10 of the last 12 quarters.

Health Information Services: forecast